Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.

Filiacions

Pleyer L:

Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria

Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria

Leisch M:

Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria

Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria

Kourakli A:

Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Padron E:

Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Maciejewski JP:

Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Xicoy Cirici B:

Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain

Kaivers J:

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany

Ungerstedt J:

Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institute, and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

Heibl S:

Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria

Patiou P:

Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Hunter AM:

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Mora E:

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Geissler K:

Fifth Medical Department, Hospital Hietzing, Vienna, Austria

Dimou M:

141st Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

Jimenez Lorenzo MJ:

Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain

Melchardt T:

Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria

Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria

Egle A:

Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria

Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria

Viniou AN:

141st Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece

Patel BJ:

Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Arnan M:

Institut Català d'Oncologia-Hospital Duran y Reynals, Hospitalet de Llobregat, Barcelona, Spain

Valent P:

Department of Internal Medicine, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria

Roubakis C:

Department of Hematology, G GENNIMATAS General Hospital, Athens, Greece

Bernal Del Castillo T:

Hospital Universitario Central Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, University Institute of Oncology of Asturias-Cajastur Social Programme, Oviedo, Spain

Galanopoulos A:

Department of Hematology, G GENNIMATAS General Hospital, Athens, Greece

Calabuig Muñoz M:

Hospital Clínico Universitario de Valencia, Valencia, Spain

Bonadies N:

Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Switzerland

Medina de Almeida A:

Hospital da Luz, Lisbon, Portugal

Centro de Investigação Interdisciplinar em Saúde, Universidade Católica Portuguesa de Lisboa, Lisbon, Portugal

Cermak J:

Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Jerez A:

Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB, Murcia, Spain

Montoro MJ:

Hematology Department, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain

Cortés A:

Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Avendaño Pita A:

Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

Lopez Andrade B:

Hematology Department Hospital Universitario Son Espases, Palma Mallorca, Spain

Hellstroem-Lindberg E:

Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institute, and Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

Germing U:

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany

Sekeres MA:

Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

List AF:

Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Symeonidis A:

Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Sanz GF:

Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Centro de Investigacion Biomedica en Red Cance, Instituto Carlos III, Madrid, Spain

Larcher-Senn J:

Assign Data Management and Biostatistics, Innsbruck, Austria

Greil R:

Third Medical Department with Hematology, Medical Oncology, Rheumatology and Infectiology, Paracelsus Medical University, Salzburg, Austria

Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials, Salzburg, Austria